Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures. | Cancers (Basel) | 2021 | 34638492 | PubTator, text mining | PubMed |
| Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2021 | 34638286 | PubTator, text mining | PubMed |
| Complement factor B in high glucose-induced podocyte injury and diabetic kidney disease. | JCI Insight | 2021 | 34622800 | PubTator, text mining | PubMed |
| System-Level Scenarios for the Elucidation of T Cell-Mediated Germinal Center B Cell Differentiation. | Front Immunol | 2021 | 34616402 | PubTator, text mining | PubMed |
| Determinants of renal cell carcinoma invasion and metastatic competence. | Nat Commun | 2021 | 34608135 | PubTator, text mining | PubMed |
| Ginsenoside Rg3 Promotes Cell Growth Through Activation of mTORC1. | Front Cell Dev Biol | 2021 | 34589493 | PubTator, text mining | PubMed |
| The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia. | Oncoimmunology | 2021 | 34589290 | PubTator, text mining | PubMed |
| Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine. | Micromachines (Basel) | 2021 | 34577765 | PubTator, text mining | PubMed |
| The Significance of MET Expression and Strategies of Targeting MET Treatment in Advanced Gastric Cancer. | Front Oncol | 2021 | 34557411 | PubTator, text mining | PubMed |
| Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy. | Invest Ophthalmol Vis Sci | 2021 | 34554178 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. | Signal Transduct Target Ther | 2021 | 34552055 | PubTator, text mining | PubMed |
| Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up. | Front Pediatr | 2021 | 34540765 | PubTator, text mining | PubMed |
| TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunity. | Sci Adv | 2021 | 34524845 | PubTator, text mining | PubMed |
| Activation of mTORC1 and c-Jun by Prohibitin1 loss in Schwann cells may link mitochondrial dysfunction to demyelination. | Elife | 2021 | 34519641 | PubTator, text mining | PubMed |
| Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. | Clin Cancer Res | 2021 | 34518313 | PubTator, text mining | PubMed |
| Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis. | Blood Cancer Discov | 2021 | 34514432 | PubTator, text mining | PubMed |
| Joint Degeneration in a Mouse Model of Pseudoachondroplasia: ER Stress, Inflammation, and Block of Autophagy. | Int J Mol Sci | 2021 | 34502142 | PubTator, text mining | PubMed |
| Single-Cell Analysis of the Neonatal Immune System Across the Gestational Age Continuum. | Front Immunol | 2021 | 34497610 | PubTator, text mining | PubMed |
| HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast. | J Hematol Oncol | 2021 | 34496925 | PubTator, text mining | PubMed |
| A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer. | Cell Oncol (Dordr) | 2021 | 34462871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=30